Related Experiment Video
Updated: Aug 16, 2026

Protocol for Dengue Infections in Mosquitoes A. aegypti and Infection Phenotype Determination
Published on: July 4, 2007
A Molecular Approach Designed to Limit the Replication of Mature DENV2 in Host Cells
Ummar Raheel1, Muhsin Jamal1, Najam Us Sahar Sadaf Zaidi1
1Atta-ur-Rahman School of Applied Biosciences (ASAB), National University of Sciences and Technology (NUST) , Islamabad, Pakistan .
Abstract:
Dengue virus (DENV) is an arthropod-borne virus, which belongs to the Flaviviridae family, and completes its life cycle in two hosts: humans and mosquitoes. For DENV maturation, the surface pre-membrane (prM) protein is cleaved to form a mature membrane protein (M) by furin, which is a cellular enzyme subsequently releasing the mature virus from the host dendritic cell. The objective of the current study was to inhibit mature DENV isotype 2 (DENV2) by RNA-interference in a Vero-81 cell line. Mature DENV2 was propagated in and isolated from U937 cells expressing dendritic cell-specific intracellular adhesion molecule-3-grabbing non-integrin. Maturation of DENV2 was confirmed by Western blot analysis, where virus stock lacking prM was considered mature. Inhibition studies were carried out by transfection of Vero-81 cells with six synthetic siRNAs along with a control siRNA. Reduction in cellular DENV2 was observed also by focus-reduction assay, immunofluorescence assay (IFA), and real-time quantitative polymerase chain reaction (RT-qPCR). Cells transfected with DENV2SsiRNA2, which was targeting the structural region M of mature DENV2, was able to reduce DENV2 titer by up to 85% in focus reduction assays. A significant reduction in mature DENV2 RNA load was observed by RT-qPCR, confirming the previous findings. IFA also revealed reduced levels of cellular DENV2. These results demonstrated that mature DENV2 can be effectively inhibited by synthetic siRNA targeting the structural region of the genome. Mature DENV2 can be successfully inhibited by siRNAs, and specifically high knock-down efficiency is observed by siRNAs against M region of mature DENV2. This study shows that M represents a potential target for RNAi based inhibitory approaches.
Insights
This study demonstrates that small interfering RNA (siRNA) targeting the M region of mature Dengue virus type 2 (DENV2) effectively inhibits viral replication. Specifically, siRNA targeting the M protein reduced DENV2 by up to 85%, highlighting M as a promising target for RNA interference therapies.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Dengue virus (DENV) is a significant arthropod-borne pathogen belonging to the Flaviviridae family, with a life cycle involving humans and mosquitoes.
- Viral maturation involves the cleavage of the pre-membrane (prM) protein to the mature membrane (M) protein by furin, crucial for virus release from host cells.
Purpose of the Study:
- To investigate the inhibition of mature Dengue virus isotype 2 (DENV2) using RNA interference (RNAi) in a Vero-81 cell line.
- To identify specific viral targets for effective RNAi-mediated DENV2 inhibition.
Main Methods:
- DENV2 was propagated and isolated from U937 cells, and maturation was confirmed by Western blot.
- Vero-81 cells were transfected with synthetic small interfering RNAs (siRNAs) targeting DENV2, including those against the M protein.
- Viral inhibition was assessed using focus-reduction assays, immunofluorescence assays (IFA), and real-time quantitative polymerase chain reaction (RT-qPCR).
Main Results:
- Transfection with siRNA targeting the M protein (DENV2SsiRNA2) reduced DENV2 titer by up to 85% in focus reduction assays.
- RT-qPCR confirmed a significant reduction in mature DENV2 RNA load.
- IFA demonstrated decreased levels of cellular DENV2 following siRNA treatment.
Conclusions:
- Mature DENV2 can be effectively inhibited by synthetic siRNAs targeting specific regions of the viral genome.
- The M protein region of mature DENV2 is a highly effective target for RNAi-based inhibitory strategies.
- This research validates M as a potential target for developing RNAi-based therapies against Dengue virus.
More Related Videos
12:30Use of a Recombinant Mosquito Densovirus As a Gene Delivery Vector for the Functional Analysis of Genes in Mosquito Larvae
Published on: October 6, 2017
08:36Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction
Published on: November 1, 2018
Related Concept Videos
DNA Bacteriophages
Viruses with RNA Genomes